These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6100173)

  • 41. In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B; Coban AY; Birinci A; Durupinar B; Erturk M
    Clin Microbiol Infect; 2002 Dec; 8(12):810-3. PubMed ID: 12519356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ceftriaxone in pediatric surgery].
    Brülhart K; Schärli AF
    Wien Med Wochenschr Suppl; 1985; 87():28-32. PubMed ID: 3856973
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative study of the semisynthetic penicillins in the experimental therapy of pneumococcal and streptococcal infections in mice].
    Rudzit EA; Radkevich TP; Pershin GN
    Antibiotiki; 1976 Apr; 21(4):352-8. PubMed ID: 1275483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftriaxone: in vitro studies and clinical evaluation.
    Gnann JW; Goetter WE; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1982 Jul; 22(1):1-9. PubMed ID: 6289734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
    De Marco A; Manca B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceftriaxone for the treatment of serious infections.
    Steele RW; Bradsher RW
    Am J Dis Child; 1983 Nov; 137(11):1044-7. PubMed ID: 6314805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins.
    Arisawa M; Ohshima J; Ohsawa E; Maruyama HB; Sekine Y; Mitsuhashi S
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2544-54. PubMed ID: 6291792
    [No Abstract]   [Full Text] [Related]  

  • 48. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.
    Chadwick EG; Yogev R; Shulman ST; Weinfeld RE; Patel IH
    J Pediatr; 1983 Jan; 102(1):134-7. PubMed ID: 6294263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ceftriaxone: renal and biliary excretion and effect on the colon microflora.
    Arvidsson A; Alván G; Angelin B; Borgå O; Nord CE
    J Antimicrob Chemother; 1982 Sep; 10(3):207-15. PubMed ID: 6292158
    [No Abstract]   [Full Text] [Related]  

  • 52. Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections.
    Nilsson-Ehle I; Nord CE; Ursing B
    Scand J Infect Dis; 1985; 17(1):77-82. PubMed ID: 3992209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceftriaxone: a three centre comparative in vitro susceptibility study.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Eur J Clin Microbiol; 1985 Apr; 4(2):142-4. PubMed ID: 4006933
    [No Abstract]   [Full Text] [Related]  

  • 54. Ceftriaxone. A new cephalosporin with aqueous humor levels effective against enterobacteriaceae.
    Axelrod JL; Newton JC; Sarakhun C; Lester RD; Merhige K; Peck RL; Francomano TJ; Sheikh MZ
    Arch Ophthalmol; 1985 Jan; 103(1):71-2. PubMed ID: 3977680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cephalexin: microbiological activity in vitro and in vivo].
    Muggleton PW; Renzini G; Ravagnan G; Orsolini P
    Antibiotica; 1969 Jun; 7(2):93-128. PubMed ID: 5399239
    [No Abstract]   [Full Text] [Related]  

  • 56. Ceftriaxone pharmacokinetics in newborn infants.
    McCracken GH; Siegel JD; Threlkeld N; Thomas M
    Antimicrob Agents Chemother; 1983 Feb; 23(2):341-3. PubMed ID: 6301369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of cefotaxime in healthy volunteers and patients.
    Patel KB; Nicolau DP; Nightingale CH; Quintiliani R
    Diagn Microbiol Infect Dis; 1995; 22(1-2):49-55. PubMed ID: 7587050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefotaxime: pharmacokinetics and in vitro antibacterial activity of serum and urine in normal human volunteers.
    Plouffe JF; Perkins RL; Fass RJ; Prior RB; Bernstein B; Ho I
    Chemotherapy; 1983; 29(2):73-9. PubMed ID: 6301775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man.
    Maudgal DP; Maxwell JD; Lees LJ; Wild RN
    Br J Clin Pharmacol; 1982 Aug; 14(2):213-7. PubMed ID: 6285946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys.
    Matsui H; Komiya M; Ikeda C; Tachibana A
    Antimicrob Agents Chemother; 1984 Aug; 26(2):204-7. PubMed ID: 6091536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.